Процессы свободно-радикального окисления и роль эритропоэтина в их коррекции у больных хронической почечной недостаточностью, находящихся на гемодиализе
Т. А. Григорьев, Mikhail V. Osikov · Современные проблемы науки и образования · 2011
We investigated status of free radical medicated oxidation and its modulation by erythropoietin in 62 dialyzed chronic renal failure patients undergoing program dialysis at Chelyabinsk regional hospital. Chronic renal failure patients displayed activation of free radical oxidation measured by levels of lipid peroxidation products in heptane and isopropanol fractions of plasma extracts. Specifically, diene conjugates, ketodienes and trienes were elevated, simultaneously, catalase and Cu-Zn-dependent SOD were diminished. Dialysis procedure failed to effect any significant action on lipid peroxidation products and antioxidative enzymes. Recombinant human erythropoietin (monthly dose about 40000 IU) displayed antioxidative action: reduction of primary and secondary lipid peroxidation products is heptane fraction, reduction of final products of lipid peroxidation in isopropanol fraction. Also, SOD and catalase activities were found to be improved compared to control group.
Cited by 0 works.